The effects of some imidazopyrazine derivatives on telomerase inhibition, mtDNA damage and mtDNA copy number
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2017Author
Mutlu, Ayşe GülBilginer, Abdulkerim
Kayağil, İsmail
Yıldız, Hülya
Bayhan, Ülkü
Yılmaz, İnanç
Demirayak, Şeref
Metadata
Show full item recordCitation
Mutlu, A. G., Bilginer, A., Kayağil, İ., Yıldız, H., Bayhan, Ü., Yılmaz, İ. ... Demirayak, Ş. (2017). The effects of some imidazopyrazine derivatives on telomerase inhibition, mtDNA damage and mtDNA copy number. Acta Pharmaceutica Sciencia, 55(3), 31-41. https://dx.doi.org/10.23893/1307-2080.APS.05517Abstract
Imidazopyrazine derivatives have been studied for their curative effects on some diseases like cancer and neurological problems; also, some of these molecules have been patented. Primary human cells exhibit limited replicative potential but the cancer cells divided unlimitedly with passage in culture. This immortality is mainly a result of telomerase activity. We investigated the possible telomerase inhibitor effect and possible mtDNA damage action of five imidazopyrazine derivatives. Telomerase activities were measured by the PCR-ELISA based TRAP method and mtDNA damage assays were achieved by quantitative PCR. We used zebrafish as a model organism for our research. In the application of 6-(4-Metylphenyl-8-(4-chlorophenyl)imidazo[1,2-a]pyrazine (C19H14N3Cl), it was determined that this compound inhibit telomerase activities to a statistically significant degree. The obtained results from molecular docking studies also supported the experimental results. Accordingly, this compound has the probability to be used as an anti-cancer agent after detailed studies.
xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q4Source
Acta Pharmaceutica ScienciaVolume
55Issue
3Collections
- Makale Koleksiyonu [273]
- Scopus İndeksli Yayınlar Koleksiyonu [6283]